QTRX 6.08 ▲ 7.61% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Quanterix Corporation

    NASDAQ: QTRX · Real-Time Price · USD
    6.08
    0.43 (7.61%)
    At close: Oct 03, 2025, 3:59 PM
    5.98
    -1.64%
    After-hours: Oct 03, 2025, 06:33 PM EDT
    7.61%
    Bid 6.07
    Market Cap 282.51M
    Revenue (ttm) 125.38M
    Net Income (ttm) -70.5M
    EPS (ttm) -1.93
    PE Ratio (ttm) -3.15
    Forward PE -4.52
    Analyst Hold
    Dividends n/a
    Ask 6.35
    Volume 698,319
    Avg. Volume (20D) 661,519
    Open 5.74
    Previous Close 5.65
    Day's Range 5.74 - 6.29
    52-Week Range 4.05 - 15.67
    Beta 1.07
    Ex-Dividend Date n/a

    About QTRX

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol QTRX
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for QTRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Quanterix Corporation is scheduled to release its earnings on Nov 11, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription
    6 months ago
    -1.79%
    Quanterix Corporation shares are trading lower aft... Unlock content with Pro Subscription
    10 months ago
    -18.26%
    Quanterix shares are trading lower. The company reported Q3 financial results.
    news image

    3 days ago · zacks.com

    All You Need to Know About Quanterix (QTRX) Rating Upgrade to Buy

    Quanterix (QTRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

    news image

    1 month ago · businesswire.com

    Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

    BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the New York State Departmen...

    news image

    1 month ago · zacks.com

    Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Quanterix (QTRX)

    Quanterix (QTRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising...

    news image

    1 month ago · businesswire.com

    Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

    BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its executive leadershi...

    news image

    1 month ago · seekingalpha.com

    Quanterix Corporation (QTRX) Q2 2025 Earnings Call Transcript

    Quanterix Corporation (NASDAQ:QTRX ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 AM ET Company Participants Joshua Young - Corporate Participant Masoud Toloue - President, CEO & Director Vand...

    news image

    1 month ago · zacks.com

    Quanterix Corporation (QTRX) Reports Q2 Loss, Misses Revenue Estimates

    Quanterix Corporation (QTRX) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to a loss of $0.25 per share a year ago.

    news image

    2 months ago · businesswire.com

    Quanterix Announces Cooperation Agreement with Kent Lake Capital

    BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announc...

    news image

    2 months ago · businesswire.com

    Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

    BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the first to market, commerc...

    news image

    2 months ago · businesswire.com

    Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announ...

    news image

    2 months ago · businesswire.com

    Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum

    BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announ...

    Add to Watchlist